ARTICLE | Clinical News
Mirapex neurology data
May 11, 2009 7:00 AM UTC
Data from a double-blind trial in 301 patients showed that augmentation, defined as an exacerbation of RLS symptoms due to pharmacological treatment, did not significantly differ between pramipexole a...